Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 4
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Each of Two Dose Levels of Sarilumab in Adults With Early Polymyalgia Rheumatica
This is a randomized, double-blind, placebo-controlled, parallel-group, Phase 4, 3-group study to assess whether treatment with sarilumab at either 150 mg q2w …
Polymyalgia Rheumatica
Estimated
~$10 – $7,500
SanofiNCT07286214
Rheumatology Patient Registry and Biorepository
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Rheumatic DiseasesAdult Onset Still DiseaseAnkylosing Spondylitis+17 more
Estimated
~$10 – $750
Yale UniversityNCT04402086
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
To understand the severity and nature of participants experiences during irAEs following immune checkpoint inhibitor immunotherapy.
ArthritisPolymyalgia RheumaticaImmune Checkpoint Inhibitors
Estimated
~$10 – $750
M.D. Anderson Cancer CenterNCT06647134